All In Biotech

Free tool

FAERS Monitor: Bupivacaine Hydrochloride

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022046 or its brand name (Bupivacaine Hydrochloride, Bupivacaine Hydrochloride, Epinephrine Bitartrate). Reports on generic versions are filed under their own applications.

Reports

2,117

Serious

1,388

66% of reports

Hospitalization

628

Death reported

225

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective581
  • maternal exposure during pregnancy197
  • anaesthetic complication196
  • off label use165
  • hypoaesthesia144
  • hypotension125
  • condition aggravated123
  • dyspnoea117
  • hypertension117
  • headache112
  • fatigue99
  • dizziness94
  • helicobacter infection91
  • vomiting90
  • fibromyalgia87

Reports by year received

View as table
YearReports
20053
200613
20077
20089
200924
201032
201110
201221
201326
201421
201594
2016280
201732
201865
201969
202094
2021135
2022241
2023182
2024270
2025282
2026207

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,042 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
anaesthetic complicationSignal196782.1680.6141,052
helicobacter infectionSignal9188.772.57,740
fibromyalgiaSignal8735.729.02,891
maternal exposure during pregnancySignal19722.019.33,937
hypoaesthesiaSignal1449.68.21,103
hypotensionSignal1256.25.2544
hypertensionSignal1175.54.6429
drug ineffectiveSignal5814.44.11,613
condition aggravatedSignal1234.03.4280
dyspnoeaSignal1172.11.764
vomiting901.91.638
dizziness941.91.538
off label use1651.91.669
headache1121.81.538
fatigue991.31.05

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.